 Wedbush analyst Matt Bryson upgraded Diebold Nixdorf Inc NYSE: DBD from Neutral to Outperform with a 5 price target. The projection reflected its strong product order flow and expected easing of supply constraints, which have posed the most considerable headwinds. 